Ear Nose Throat (ENT) Treatment Market (By Devices: Hearing Aid Devices, Voice Prosthesis, Nasal Splints, Hearing Implants, Endoscopes, Others; By Drug Type: Antibiotics, Antihistamines, Steroids, Anti-inflammatory Drugs, Others; By Organ Type: Ear, Nose, Throat; By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030


The global ear nose throat (ENT) treatment market size was estimated at US$ 16.15 billion in 2021 and is expected to reach over US$ 27.95 billion by 2030 poised to grow at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030.

ENT Treatment Market Size 2022 to 2030

Growth Factors

The human body’s ENT stands for ears, nose, and throat, which are all interrelated. Medical and surgical management and treatment of ailments such as common cold, tonsilitis, esophageal abnormalities, and others are included in ear nose throat (ENT) treatment. An otolaryngologist is the specialist who deals with ear nose throat (ENT) problems. The rapid degradation of environmental factors that lead to various allergic reactions, congested living conditions, growing instances of anti-bacterial resistance, development in research and development activities on allergic diseases, and a growing geriatric population are all factors that support of the ear nose throat (ENT) treatment market. High treatment costs and related adverse effects, on the other hand, may limit the ear nose throat (ENT) treatment market expansion. During the projection period, advancements in antibiotics and rising physician use present multiple prospects for ear nose throat (ENT) treatment market growth during the forecast period.

The nose, ear, and throat are all in close proximity. These have distinct but related roles. The hearing, sense of smell, and balancing are all dependent on the nose and ears, which are sensory organs. The throat acts as a medium for solid and liquid food to reach the throat as well as air to reach the lungs. General practitioners usually diagnose and treat problems involving these organs, although otolaryngologists are experts in this field. The ear nose throat (ENT) devices are instruments used in diagnosis, surgery, and therapy of diseases with these organs.

Scope of the ENT Treatment Market

Report Coverage Details
Market Size US$ 27.95 Billion by 2030
Growth Rate CAGR of 6.3% from 2022 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Devices, Drug Type, Organ Type, End User, Region
Companies Mentioned Novartis AG, Pfizer Inc., GlaxoSmithKline Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Starkey Laboratories Inc., Siemens Healthcare, Sonic Innovations Inc., American Hearing Systems Inc., Dr. Reddy’s Laboratories Ltd.

 

A significant driver for the global ear nose throat (ENT) treatment market is the growing global geriatric population as well as the rising prevalence of different ear, nose, and throat ailments. Depending on the type of care given for the patient, products or devices in the worldwide ear nose throat (ENT) treatment market are utilized for a number of activities. Increased pressure on the healthcare industry to cut costs, significant investments by governments and private sector players in the development of healthcare technologies and infrastructure, and favorable reimbursement regulations and laws in some emerging and established nations are all expected to drive the global ear nose throat (ENT) treatment market in near future. In the upcoming years, surge in demand for cosmetic ear nose throat (ENT) operations could create a number of profitable opportunities for key market players in the global ear nose throat (ENT) treatment market. However, the high cost of devices and carbon dioxide lasers may limit the growth of the global ear nose throat (ENT) treatment market during the forecast period.

The expanding use of various supportive devices in the healthcare sectors is directly influenced by rising awareness of device availability in the global ear nose throat (ENT) treatment market. Governments all around the world are seen providing vital education to raise knowledge of various cost-effective and efficient medical gadgets such as ear nose throat (ENT) diagnostics and hearing aid devices. The global ear nose throat (ENT) treatment market is predicted to increase in the future years due to government assistance in the form of funding, grants, and subsidies as well as rising consumer demand for nose corrective operations.

Thus, the rising disposable income and increasing affordability for ear nose throat (ENT) treatment, expanding product availability and awareness, and improved healthcare expenditure and infrastructure are all factors contributing to the expansion of the global ear nose throat (ENT) treatment market during the forecast period.

Devices Insights

In 2020, the hearing aid devices segment dominated the ear nose throat (ENT) treatment market. This is due to the entry of new companies, increasing usage of these devices, and technological developments as a result of market players’ increased research and development spending.

The endoscopes segment, on the other hand, is predicted to develop at the quickest rate in the future years. This is attributed to the endoscopic research and development, which has resulted in the introduction of effective and diverse types of endoscopes for surgeries.

End User Insights

In 2020, the hospitals segment dominated the ear nose throat (ENT) treatment market. The primary driving factors for the segment are increased disposable income, improved healthcare infrastructure and expenditure, increasing affordability of ear nose throat (ENT) treatment, and rising knowledge and awareness of the procedure’s success or failure.

The ambulatory surgical centers segment, on the other hand, is predicted to develop at the quickest rate in the future years. Ambulatory surgical centers are outpatient surgery centers where patients can have surgery the same day, they are admitted without having to remain overnight. These centers provide diagnostic and preventative services.

Region Insights

North America dominated the ear nose throat (ENT) treatment market in 2020. This is due to the region’s high frequency of ear nose throat (ENT) related illnesses, surge in demand for hearing aids, and the presence of large hospital chains, huge target population, and well-equipped ambulatory facilities.

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. This is attributed to the rising healthcare expenditure, growing awareness about early diseases diagnosis, and increased investment by major market players.

Key Developments

  • Otonomy Inc., based in the U.S. got FDA approval in December 2015 for the commercialization for its novel antibiotic OTIPRIO for the treatment of young patients with bilateral otitis media.
  • WIDEX MOMENT, the first generation of hearing aids that sound natural, was launched by WS Audiology in March 2020. Widex’s unique ZeroDelay Technology makes this possible.
  • Cochlear Limited and GN Hearing teamed up with Google in September 2019 to announce support for direct streaming from Android devices to hearing equipment through Bluetooth Low Energy.
  • Sonova Holding AG plans to extend its ear nose throat (ENT) product research and commercial manufacturing in 2020 by opening World of Hearing, a new hearing solution store in the Netherlands. Sonova Holding AG introduced innovative technology that allows hearing aid fittings to be completed remotely.

The ear nose throat (ENT) treatment market is highly fragmented, with a huge number of small and large businesses competing. As a result, micro and medium firms are forced to compete fiercely to maintain their market position and to expand customer reach. As a result, industry competition between major market players is expected to be fierce during the projection period. Furthermore, important firms are helping to build the ear nose throat (ENT) treatment market by collaborations and launching new products and devices in the market.  

Some of the prominent players in the global ear nose throat (ENT) treatment market include:

  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline Pharmaceuticals
  • Teva Pharmaceuticals Industries Ltd.
  • Sonova Holding AG
  • Starkey Laboratories Inc.
  • Siemens Healthcare
  • Sonic Innovations Inc.
  • American Hearing Systems Inc.
  • Dr. Reddy’s Laboratories Ltd.

Segments Covered in the Report

By Devices

  • Hearing Aid Devices
  • Voice Prosthesis
  • Nasal Splints
  • Hearing Implants
  • Endoscopes
  • Others

By Drug Type

  • Antibiotics
  • Antihistamines
  • Steroids
  • Anti-inflammatory Drugs
  • Others

By Organ Type

  • Ear
  • Nose
  • Throat

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of ENT treatment market?
According to Precedence Research, the global ear nose throat (ENT) treatment market size was valued at US$ 16.15 billion in 2021 and is anticipated to hit over US$ 27.95 billion by 2030.
The global ear nose throat (ENT) treatment market is expected to drive growth at a CAGR of 6.3% from 2022 to 2030.
The rising elderly population, rising prevalence of ear nose throat (ENT)-related illnesses, and rising adoption of less invasive ear nose throat (ENT) operations are some of the significant market drivers of the ear nose throat (ENT) treatment market.
The major players operating in the ENT treatment market are Novartis AG, Pfizer Inc., GlaxoSmithKline Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Starkey Laboratories Inc., Siemens Healthcare, Sonic Innovations Inc., American Hearing Systems Inc., Dr. Reddy’s Laboratories Ltd.
North America region will lead the global ENT treatment market during the forecast period 2022 to 2030.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample